{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:07:48Z","timestamp":1784635668343,"version":"3.55.0"},"reference-count":104,"publisher":"Walter de Gruyter GmbH","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hepatic encephalopathy (HE) encompasses a wide spectrum of neuropsychiatric disturbances that arise as a consequence of acute or chronic liver dysfunction. It represents a critical event in the natural history of cirrhosis and serves as an independent predictor of morbidity and mortality in affected patients worldwide. The clinical manifestations of HE range from subtle cognitive impairments, such as poor concentration, memory deficits, anxiety, depression, and insomnia, to severe psychomotor abnormalities, disorientation, and coma. Hyperammonemia is widely regarded as the central hallmark of HE pathogenesis and remains a cornerstone in both diagnosis and therapeutic monitoring. However, elevated ammonia levels do not always correlate with clinical severity, and some patients may present with significant neurological impairment despite near-normal ammonia concentrations. This discrepancy highlights the multifactorial mechanisms underlying HE, including neuroinflammation, oxidative stress, alterations in neurotransmission, and gut\u2013liver\u2013brain axis dysregulation. In this review, we provide a comprehensive overview of the pathogenesis, clinical spectrum, diagnostic approaches, and current as well as emerging therapeutic strategies for hepatic encephalopathy, with a focus on recent advances that may improve patient outcomes.<\/jats:p>","DOI":"10.1515\/jbcpp-2025-0166","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T10:07:49Z","timestamp":1779962869000},"page":"293-303","source":"Crossref","is-referenced-by-count":0,"title":["New insight on hepatic encephalopathy: a comprehensive review"],"prefix":"10.1515","volume":"37","author":[{"given":"Ahmed A.","family":"Sedik","sequence":"first","affiliation":[{"name":"Pharmacology Department , Medical Research and Clinical Studies Institute, National Research Centre , Cairo , Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renad","family":"Alrefaei","sequence":"additional","affiliation":[{"name":"College of Medicine, Taibah University , Madinah , Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_001","doi-asserted-by":"crossref","unstructured":"Sedik, AA, Hussein, DT, Fathy, K, Mowaad, NA. Neuroprotective and cognitive enhancing effects of herbecetin against thioacetamide induced hepatic encephalopathy in rats via upregulation of AMPK and SIRT1 signaling pathways. Sci Rep 2024;14:11396. https:\/\/doi.org\/10.1038\/s41598-024-61639-6.","DOI":"10.1038\/s41598-024-61639-6"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_002","doi-asserted-by":"crossref","unstructured":"Butterworth, RF. Hepatic encephalopathy. In: The liver: biology and pathobiology; 2020:615\u201329 pp.","DOI":"10.1002\/9781119436812.ch48"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_003","doi-asserted-by":"crossref","unstructured":"Cantu, RC, Gean, AD. Second-impact syndrome and a small subdural hematoma: an uncommon catastrophic result of repetitive head injury with a characteristic imaging appearance. J\u00a0Neurotrauma 2010;27:1557\u201364. https:\/\/doi.org\/10.1089\/neu.2010.1334.","DOI":"10.1089\/neu.2010.1334"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_004","doi-asserted-by":"crossref","unstructured":"Wu, S, Li, L, Xi, H, Wu, X, He, Y, Sun, X, et al.. Bibliometrics and knowledge mapping of the pathogenesis of hepatic encephalopathy in patients with liver cirrhosis. Heliyon 2024;10. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34330.","DOI":"10.1016\/j.heliyon.2024.e34330"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_005","doi-asserted-by":"crossref","unstructured":"Kimura, H, Nagai, Y, Umemura, K, Kimura, Y. Physiological roles of hydrogen sulfide: synaptic modulation, neuroprotection, and smooth muscle relaxation. Antioxid Redox Signal 2005;7:795\u2013803. https:\/\/doi.org\/10.1089\/ars.2005.7.795.","DOI":"10.1089\/ars.2005.7.795"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_006","doi-asserted-by":"crossref","unstructured":"Norenberg, MD, Jayakumar, AR, Rama Rao, KV, Panickar, KS. New concepts in the mechanism of ammonia-induced astrocyte swelling. Metab Brain Dis 2007;22:219\u201334. https:\/\/doi.org\/10.1007\/s11011-007-9062-5.","DOI":"10.1007\/s11011-007-9062-5"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_007","doi-asserted-by":"crossref","unstructured":"Ferenci, P, Lockwood, A, Mullen, K, Tarter, R, Weissenborn, K, Blei, AT. Hepatic encephalopathy\u00a0\u2013\u00a0definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716\u201321. https:\/\/doi.org\/10.1053\/jhep.2002.31250.","DOI":"10.1053\/jhep.2002.31250"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_008","doi-asserted-by":"crossref","unstructured":"Sedik, AA, Hassan, A, Saleh, DO. Neuromodulatory role of L-arginine: nitric oxide precursor against thioacetamide-induced-hepatic encephalopathy in rats via downregulation of NF-\u03baB-mediated apoptosis. Environ Sci Pollut Control Ser 2023;30:84791\u2013804. https:\/\/doi.org\/10.1007\/s11356-023-28184-7.","DOI":"10.1007\/s11356-023-28184-7"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_009","doi-asserted-by":"crossref","unstructured":"Ford, JD. Treatment implications of altered affect regulation and information processing following child maltreatment. Psychiatr Ann 2017;35:410\u201319. https:\/\/doi.org\/10.3928\/00485713-20050501-07.","DOI":"10.3928\/00485713-20050501-07"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_010","doi-asserted-by":"crossref","unstructured":"Oakley, DA, Halligan, PW. Hypnotic suggestion and cognitive neuroscience. Trends Cognit Sci 2009;13:264\u201370. https:\/\/doi.org\/10.1016\/j.tics.2009.03.004.","DOI":"10.1016\/j.tics.2009.03.004"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_011","unstructured":"Gorman, LM, Sultan, DF. Psychosocial nursing for general patient care. Philadelphia: F. A. Davis; 2007."},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_012","doi-asserted-by":"crossref","unstructured":"Cadranel, J-F, Lebiez, E, Di Martino, V, Bernard, B, El Koury, S, Tourbah, A, et al.. Focal neurological signs in hepatic encephalopathy in cirrhotic patients: an underestimated entity? Am J Gastroenterol 2001;96:515. https:\/\/doi.org\/10.1111\/j.1572-0241.2001.03552.x.","DOI":"10.1111\/j.1572-0241.2001.03552.x"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_013","doi-asserted-by":"crossref","unstructured":"Lewis, M, Howdle, P. Neurologic complications of liver transplantation in adults. Neurology 2003;61:1174\u20138. https:\/\/doi.org\/10.1212\/01.wnl.0000089487.42870.c6.","DOI":"10.1212\/01.WNL.0000089487.42870.C6"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_014","doi-asserted-by":"crossref","unstructured":"Afifi, NA, Ramadan, A, Erian, EY, Sedik, AA, Amin, MM, Hassan, A, et al.. Synergistic effect of aminoguanidine and l-carnosine against thioacetamide-induced hepatic encephalopathy in rats: behavioral, biochemical, and ultrastructural evidence. Can J Physiol Pharmacol 2021;99:332\u201347. https:\/\/doi.org\/10.1139\/cjpp-2020-0212.","DOI":"10.1139\/cjpp-2020-0212"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_015","doi-asserted-by":"crossref","unstructured":"Nardelli, S, Gioia, S, Ridola, L, Farcomeni, A, Merli, M, Riggio, O. Proton pump inhibitors are associated with minimal and overt hepatic encephalopathy and increased mortality in patients with cirrhosis. Hepatology 2019;70:640\u20139. https:\/\/doi.org\/10.1002\/hep.30304.","DOI":"10.1002\/hep.30304"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_016","doi-asserted-by":"crossref","unstructured":"Romero\u2010G\u00f3mez, M, C\u00f3rdoba, J, Jover, R, del Olmo, JA, Ram\u00edrez, M, Rey, R, et al.. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 2007;45:879\u201385. https:\/\/doi.org\/10.1002\/hep.21586.","DOI":"10.1002\/hep.21586"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_017","doi-asserted-by":"crossref","unstructured":"Amodio, P, Del Piccolo, F, Petten\u00f2, E, Mapelli, D, Angeli, P, Iemmolo, R, et al.. Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. J\u00a0Hepatol 2001;35:37\u201345. https:\/\/doi.org\/10.1016\/s0168-8278(01)00129-5.","DOI":"10.1016\/S0168-8278(01)00129-5"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_018","doi-asserted-by":"crossref","unstructured":"Nahon, P, Bourcier, V, Layese, R, Audureau, E, Cagnot, C, Marcellin, P, et al.. Eradication of hepatitis C virus infection in patients with cirrhosis reduces risk of liver and non-liver complications. Gastroenterology 2017;152:142\u201356.e2. https:\/\/doi.org\/10.1053\/j.gastro.2016.09.009.","DOI":"10.1053\/j.gastro.2016.09.009"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_019","unstructured":"Benhaddouch, Z, Abidi, K, Naoufel, M, Abouqal, R, Zeggwagh, AA. Mortality and prognostic factors of the cirrhotic patients with hepatic encephalopathy admitted to medical intensive care unit. In: Annales francaises d\u2019anesthesie et de reanimation; 2007."},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_020","doi-asserted-by":"crossref","unstructured":"Belghiti, J, Carr, BI, Greig, PD, Lencioni, R, Poon, RT. Treatment before liver transplantation for HCC. Ann Surg Oncol 2008;15:993\u20131000. https:\/\/doi.org\/10.1245\/s10434-007-9787-8.","DOI":"10.1245\/s10434-007-9787-8"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_021","doi-asserted-by":"crossref","unstructured":"Tapper, EB, Parikh, ND, Sengupta, N, Mellinger, J, Ratz, D, Lok, AS, et al.. A risk score to predict the development of hepatic encephalopathy in a population\u2010based cohort of patients with cirrhosis. Hepatology 2018;68:1498\u2013507. https:\/\/doi.org\/10.1002\/hep.29628.","DOI":"10.1002\/hep.29628"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_022","doi-asserted-by":"crossref","unstructured":"Orman, ES, Roberts, A, Ghabril, M, Nephew, L, Desai, AP, Patidar, K, et al.. Trends in characteristics, mortality, and other outcomes of patients with newly diagnosed cirrhosis. JAMA Netw Open 2019;2:e196412. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.6412.","DOI":"10.1001\/jamanetworkopen.2019.6412"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_023","doi-asserted-by":"crossref","unstructured":"Potnis, A, VanMeter, S, Stange, J. Prevalence of hepatic encephalopathy from a commercial medical claims database in the United\u00a0States. Int J Hepatol 2021;2021:8542179. https:\/\/doi.org\/10.1155\/2021\/8542179.","DOI":"10.1155\/2021\/8542179"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_024","doi-asserted-by":"crossref","unstructured":"Shiha, G, Mousa, N. Minimal hepatic encephalopathy: silent tragedy. Liver Dis Surg 2019;2019.","DOI":"10.5772\/intechopen.88231"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_025","doi-asserted-by":"crossref","unstructured":"Shawcross, DL, Shabbir, SS, Taylor, NJ, Hughes, RD. Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology 2010;51:1062\u20139. https:\/\/doi.org\/10.1002\/hep.23367.","DOI":"10.1002\/hep.23367"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_026","doi-asserted-by":"crossref","unstructured":"Shawcross, D, Wright, G, Olde Damink, SWM, Jalan, R. Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab Brain Dis 2007;22:125\u201338. https:\/\/doi.org\/10.1007\/s11011-006-9042-1.","DOI":"10.1007\/s11011-006-9042-1"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_027","doi-asserted-by":"crossref","unstructured":"Hung, T, Lay, CJ, Chang, CM, Tsai, JJ, Tsai, CC, Tsai, CC. The effect of infections on the mortality of cirrhotic patients with hepatic encephalopathy. Epidemiol Infect 2013;141:2671\u20138. https:\/\/doi.org\/10.1017\/s0950268813000186.","DOI":"10.1017\/S0950268813000186"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_028","doi-asserted-by":"crossref","unstructured":"Hernandez-Rabaza, V, Agusti, A, Cabrera-Pastor, A, Fustero, S, Delgado, O, Taoro-Gonzalez, L, et al.. Sildenafil reduces neuroinflammation and restores spatial learning in rats with hepatic encephalopathy: underlying mechanisms. J\u00a0Neuroinflammation 2015;12:1\u201312. https:\/\/doi.org\/10.1186\/s12974-015-0420-7.","DOI":"10.1186\/s12974-015-0420-7"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_029","doi-asserted-by":"crossref","unstructured":"Poh, Z, Chang, P. A current review of the diagnostic and treatment strategies of hepatic encephalopathy. Int J Hepatol 2012:2012. https:\/\/doi.org\/10.1155\/2012\/480309.","DOI":"10.1155\/2012\/480309"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_030","doi-asserted-by":"crossref","unstructured":"Jover, R, Zapater, P, Castells, A, Llor, X, Andreu, M, Cubiella, J, et al.. Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer. Gut 2006;55:848\u201355. https:\/\/doi.org\/10.1136\/gut.2005.073015.","DOI":"10.1136\/gut.2005.073015"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_031","doi-asserted-by":"crossref","unstructured":"Hadjihambi, A, Arias, N, Sheikh, M, Jalan, R. Hepatic encephalopathy: a critical current review. Hepatol Int 2018;12:135\u201347. https:\/\/doi.org\/10.1007\/s12072-017-9812-3.","DOI":"10.1007\/s12072-017-9812-3"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_032","doi-asserted-by":"crossref","unstructured":"Gallego-Dur\u00e1n, R, Hadjihambi, A, Ampuero, J, Rose, CF, Jalan, R, Romero-G\u00f3mez, M. Ammonia-induced stress response in liver disease progression and hepatic encephalopathy. Nat Rev Gastroenterol Hepatol 2024:1\u201318. https:\/\/doi.org\/10.1038\/s41575-024-00970-9.","DOI":"10.1038\/s41575-024-00970-9"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_033","doi-asserted-by":"crossref","unstructured":"Prasad, SK, Acharjee, A, Singh, VV, Trigun, SK, Acharjee, P. Modulation of brain energy metabolism in hepatic encephalopathy: impact of glucose metabolic dysfunction. Metab Brain Dis 2024:1\u201317. https:\/\/doi.org\/10.1007\/s11011-024-01407-7.","DOI":"10.1007\/s11011-024-01407-7"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_034","doi-asserted-by":"crossref","unstructured":"Simicic, D, Cudalbu, C, Pierzchala, K. Overview of oxidative stress findings in hepatic encephalopathy: from cellular and ammonium-based animal models to human data. Anal Biochem 2022;654:114795. https:\/\/doi.org\/10.1016\/j.ab.2022.114795.","DOI":"10.1016\/j.ab.2022.114795"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_035","doi-asserted-by":"crossref","unstructured":"Lu, K. Cellular pathogenesis of hepatic encephalopathy: an update. Biomolecules 2023;13:396. https:\/\/doi.org\/10.3390\/biom13020396.","DOI":"10.3390\/biom13020396"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_036","doi-asserted-by":"crossref","unstructured":"Zadak, Z, Hy\u0161pler, R, Tich\u00e1, A, Hronek, M, Fikrov\u00e1, P, Rathousk\u00e1, J, et al.. Antioxidants and vitamins in clinical conditions. Physiol Res 2009;58:S13\u201317. https:\/\/doi.org\/10.33549\/physiolres.931861.","DOI":"10.33549\/physiolres.931861"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_037","unstructured":"Hadeer, AA, AL-Kaisie, BI. Pathological and biochemical study on liver of male mice intoxicated with thioacetamide. J Entomol Zool Stud 2018;6:1436\u201341."},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_038","doi-asserted-by":"crossref","unstructured":"Cao, L, Quan, XB, Zeng, WJ, Yang, XO, Wang, MJ. Mechanism of hepatocyte apoptosis. J\u00a0Cell Death 2016;9:JCD. S39824. https:\/\/doi.org\/10.4137\/jcd.s39824.","DOI":"10.4137\/JCD.S39824"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_039","doi-asserted-by":"crossref","unstructured":"Butterworth, RF. Hepatic encephalopathy: a central neuroinflammatory disorder? Hepatology 2011;53:1372\u20136. https:\/\/doi.org\/10.1002\/hep.24228.","DOI":"10.1002\/hep.24228"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_040","doi-asserted-by":"crossref","unstructured":"Bouabid, S, Tinakoua, A, Lakhdar\u2010Ghazal, N, Benazzouz, A. Manganese neurotoxicity: behavioral disorders associated with dysfunctions in the basal ganglia and neurochemical transmission. J\u00a0Neurochem 2016;136:677\u201391. https:\/\/doi.org\/10.1111\/jnc.13442.","DOI":"10.1111\/jnc.13442"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_041","doi-asserted-by":"crossref","unstructured":"Dorman, DC. The role of oxidative stress in manganese neurotoxicity: a literature review focused on contributions made by Professor Michael Aschner. Biomolecules 2023;13:1176. https:\/\/doi.org\/10.3390\/biom13081176.","DOI":"10.3390\/biom13081176"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_042","doi-asserted-by":"crossref","unstructured":"Tarnacka, B, Jopowicz, A, Ma\u015bli\u0144ska, M. Copper, iron, and manganese\u00a0toxicity in neuropsychiatric conditions. Int J Mol Sci 2021;22:7820. https:\/\/doi.org\/10.3390\/ijms22157820.","DOI":"10.3390\/ijms22157820"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_043","doi-asserted-by":"crossref","unstructured":"Dike, C, Antia, M, Bababtunde, B, Sikoki, F, Ezejiofor, A. Cognitive, sensory, and motor impairments associated with aluminium, manganese, mercury and lead exposures in the onset of neurodegeneration. IPS J Public Health 2023;2:1\u201317. https:\/\/doi.org\/10.54117\/ijph.v2i1.9.","DOI":"10.54117\/ijph.v2i1.9"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_044","doi-asserted-by":"crossref","unstructured":"Tinkov, AA, Paoliello, MMB, Mazilina, AN, Skalny, AV, Martins, AC, Voskresenskaya, ON, et al.. Molecular targets of manganese-induced neurotoxicity: a five-year update. Int J Mol Sci 2021;22:4646. https:\/\/doi.org\/10.3390\/ijms22094646.","DOI":"10.3390\/ijms22094646"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_045","doi-asserted-by":"crossref","unstructured":"Guan, R, Wang, T, Dong, X, Du, K, Li, J, Zhao, F, et al.. Effects of co-exposure to lead and manganese on learning and memory deficits. J\u00a0Environ Sci 2022;121:65\u201376. https:\/\/doi.org\/10.1016\/j.jes.2021.09.012.","DOI":"10.1016\/j.jes.2021.09.012"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_046","doi-asserted-by":"crossref","unstructured":"Fox, R, Stenning, K, Slee, A, Macnaughtan, J, Davies, N. Sarcopenia in liver cirrhosis: prevalence, pathophysiology and therapeutic strategies. Anal Biochem 2022;647:114581. https:\/\/doi.org\/10.1016\/j.ab.2022.114581.","DOI":"10.1016\/j.ab.2022.114581"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_047","doi-asserted-by":"crossref","unstructured":"Ebadi, M, Bhanji, RA, Mazurak, VC, Montano-Loza, AJ. Sarcopenia in cirrhosis: from pathogenesis to interventions. J\u00a0Gastroenterol 2019;54:845\u201359. https:\/\/doi.org\/10.1007\/s00535-019-01605-6.","DOI":"10.1007\/s00535-019-01605-6"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_048","doi-asserted-by":"crossref","unstructured":"Kumar, R, Prakash, SS, Priyadarshi, RN, Anand, U. Sarcopenia in chronic liver disease: a metabolic perspective. J\u00a0Clin Transl Hepatol 2022;10:1213. https:\/\/doi.org\/10.14218\/JCTH.2022.00239.","DOI":"10.14218\/JCTH.2022.00239"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_049","doi-asserted-by":"crossref","unstructured":"Cespiati, A, Smith, D, Lombardi, R, Fracanzani, AL. The negative impact of sarcopenia on hepatocellular carcinoma treatment outcomes. Cancers 2024;16:2315. https:\/\/doi.org\/10.3390\/cancers16132315.","DOI":"10.3390\/cancers16132315"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_050","doi-asserted-by":"crossref","unstructured":"Ding, A, Lee, A, Callender, M, Loughrey, M, Quah, SP, Dinsmore, WW. Hepatic encephalopathy as an unusual late complication of transjugular intrahepatic portosystemic shunt insertion for non-cirrhotic portal hypertension caused by nodular regenerative hyperplasia in an HIV-positive patient on highly active antiretroviral therapy. Int J STD AIDS 2010;21:71\u20132. https:\/\/doi.org\/10.1258\/ijsa.2009.009038.","DOI":"10.1258\/ijsa.2009.009038"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_051","doi-asserted-by":"crossref","unstructured":"C\u00f3rdoba, J. New assessment of hepatic encephalopathy. J\u00a0Hepatol 2011;54:1030\u201340. https:\/\/doi.org\/10.1016\/j.jhep.2010.11.015.","DOI":"10.1016\/j.jhep.2010.11.015"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_052","doi-asserted-by":"crossref","unstructured":"Chamorro, AJ, Marcos-Martin, M, Martin-Polo, J, Carlos Garcia-Diez, L, Luna, G. Wernicke encephalopathy in alcoholics with diabetic ketoacidosis. Intern Med 2009;48:1187\u20139. https:\/\/doi.org\/10.2169\/internalmedicine.48.2100.","DOI":"10.2169\/internalmedicine.48.2100"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_053","doi-asserted-by":"crossref","unstructured":"Perazzo, JC, Tallis, S, Delfante, A, Souto, PA, Lemberg, A, Eizayaga, FX, et al.. Hepatic encephalopathy: an approach to its multiple pathophysiological features. World J Hepatol 2012;4:50. https:\/\/doi.org\/10.4254\/wjh.v4.i3.50.","DOI":"10.4254\/wjh.v4.i3.50"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_054","doi-asserted-by":"crossref","unstructured":"Romero-G\u00f3mez, M, Boza, F, Garc\u00eda-Valdecasas, MS, Garc\u00eda, E, Aguilar-Reina, J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001;96:2718\u201323. https:\/\/doi.org\/10.1016\/s0002-9270(01)02692-2.","DOI":"10.1111\/j.1572-0241.2001.04130.x"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_055","doi-asserted-by":"crossref","unstructured":"Schiff, ER, Maddrey, WC, Reddy, KR. Schiff\u2019s diseases of the liver. Hoboken (NJ): John Wiley & Sons; 2017.","DOI":"10.1002\/9781119251316"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_056","doi-asserted-by":"crossref","unstructured":"Konopacka, A, Konopacki, FA, Albrecht, J. Protein kinase G is involved in ammonia\u2010induced swelling of astrocytes. J\u00a0Neurochem 2009;109:246\u201351. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.05802.x.","DOI":"10.1111\/j.1471-4159.2009.05802.x"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_057","doi-asserted-by":"crossref","unstructured":"Singh, NK, Singh, P, Varshney, P, Singh, A, Bhushan, B. Multimodal action of phosphodiesterase 5 inhibitors against neurodegenerative disorders: an update review. J\u00a0Biochem Mol Toxicol 2024;38:e70021. https:\/\/doi.org\/10.1002\/jbt.70021.","DOI":"10.1002\/jbt.70021"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_058","doi-asserted-by":"crossref","unstructured":"Jaeger, V, DeMorrow, S, McMillin, M. The direct contribution of astrocytes and microglia to the pathogenesis of hepatic encephalopathy. J\u00a0Clin Transl Hepatol 2019;7:352. https:\/\/doi.org\/10.14218\/jcth.2019.00025.","DOI":"10.14218\/JCTH.2019.00025"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_059","doi-asserted-by":"crossref","unstructured":"Aldridge, DR, Tranah, EJ, Shawcross, DL. Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation. J\u00a0Clin Exp Hepatol 2015;5:S7\u201320. https:\/\/doi.org\/10.1016\/j.jceh.2014.06.004.","DOI":"10.1016\/j.jceh.2014.06.004"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_060","doi-asserted-by":"crossref","unstructured":"Montoliu, C, Piedrafita, B, Serra, MA, del Olmo, JA, Urios, A, Rodrigo, JM, et al.. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy. J\u00a0Clin Gastroenterol 2009;43:272\u20139. https:\/\/doi.org\/10.1097\/mcg.0b013e31815e7f58.","DOI":"10.1097\/MCG.0b013e31815e7f58"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_061","doi-asserted-by":"crossref","unstructured":"Li, J, Liu, Y, Li, M, Rong, X, Yuan, Z, Ren, C, et al.. Association of preoperative IL-6 levels with overt HE in patients with cirrhosis after TIPS. Hepatol Commun 2023;7:e0128. https:\/\/doi.org\/10.1097\/hc9.0000000000000128.","DOI":"10.1097\/HC9.0000000000000128"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_062","doi-asserted-by":"crossref","unstructured":"Gairing, SJ, Anders, J, Kaps, L, Nagel, M, Michel, M, Kremer, WM, et al.. Evaluation of IL\u20106 for stepwise diagnosis of minimal hepatic encephalopathy in patients with liver cirrhosis. Hepatol Commun 2022;6:1113\u201322. https:\/\/doi.org\/10.1002\/hep4.1883.","DOI":"10.1002\/hep4.1883"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_063","doi-asserted-by":"crossref","unstructured":"Luo, M, Li, L, Yang, EN, Dai, CY, Liang, SR, Cao, WK. Correlation between interleukin-6 and ammonia in patients with overt hepatic encephalopathy due to cirrhosis. Clin Res Hepatol Gastroenterol 2013;37:384\u201390. https:\/\/doi.org\/10.1016\/j.clinre.2012.08.007.","DOI":"10.1016\/j.clinre.2012.08.007"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_064","doi-asserted-by":"crossref","unstructured":"Salama, A, Gouida, MSO, Yassen, NN, Sedik, AA. Immunoregulatory role of hesperidin against ovalbumin (OVA)-induced bronchial asthma and depression in rats. Naunyn-Schmied Arch Pharmacol 2024;397:3363\u201378. https:\/\/doi.org\/10.1007\/s00210-023-02833-7.","DOI":"10.1007\/s00210-023-02833-7"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_065","unstructured":"Sedik, A, Hassan, SA. Attenuation of sodium fluoride-induced hepatic injury by Lactobacillus casei through inhibition of NF-\u03ba\u03b2 signalling pathway with decreased expression of caspase-3 in rats. Egypt J Chem 2023;66:107\u201323."},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_066","doi-asserted-by":"crossref","unstructured":"Komala, A, Mustika, S, Pratomo, B. Overview of serum interleukin-18 (IL-18) levels in liver cirrhosis patients and their correlation to hepatic encephalopathy. Indones J Gastroenterol, Hepatol Dig Endosc 2020;19:67\u201373. https:\/\/doi.org\/10.24871\/192201867-73.","DOI":"10.24871\/192201867-73"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_067","doi-asserted-by":"crossref","unstructured":"Wunsch, E, Koziarska, D, Milkiewicz, M, Naprawa, G, Nowacki, P, Hartleb, M, et al.. In patients with liver cirrhosis, proinflammatory interleukins correlate with health-related quality of life irrespective of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol 2013;25:1402\u20137. https:\/\/doi.org\/10.1097\/meg.0b013e328365a447.","DOI":"10.1097\/MEG.0b013e328365a447"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_068","doi-asserted-by":"crossref","unstructured":"Tan, L, Meng, Y, Zeng, T, Wang, Q, Long, T, Wu, S, et al.. Clinical diagnostic significance of prealbumin, cholinesterase and retinol binding protein in liver cirrhosis combined with encephalopathy. Br J Biomed Sci 2019;76:24\u20138. https:\/\/doi.org\/10.1080\/09674845.2018.1523673.","DOI":"10.1080\/09674845.2018.1523673"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_069","doi-asserted-by":"crossref","unstructured":"Stockhoff, L, Muellner\u2010Bucsics, T, Markova, AA, Schultalbers, M, Keimburg, SA, Tergast, TL, et al.. Low serum cholinesterase identifies patients with worse outcome and increased mortality after TIPS. Hepatol Commun 2022;6:621\u201332. https:\/\/doi.org\/10.1002\/hep4.1829.","DOI":"10.1002\/hep4.1829"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_070","unstructured":"Murakami, T, Shimizu, H, Yogi, N, Hosokawa, I, Nojima, H, Ohno, T, et al.. A case of perihilar cholangiocarcinoma with postoperative hepatic encephalopathy due to portosystemic shunt treated by percutaneous embolization. Gan to Kagaku ryoho. Cancer Chemother 2023;50:102\u20134."},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_071","doi-asserted-by":"crossref","unstructured":"Witt, J-A, Alpherts, W, Helmstaedter, C. Computerized neuropsychological testing in epilepsy: overview of available tools. Seizure 2013;22:416\u201323. https:\/\/doi.org\/10.1016\/j.seizure.2013.04.004.","DOI":"10.1016\/j.seizure.2013.04.004"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_072","doi-asserted-by":"crossref","unstructured":"Gallego, JJ, Fiorillo, A, Casanova-Ferrer, F, L\u00f3pez-Gramaje, A, Urios, A, Montoliu, C. Psychometric methods for diagnosing and monitoring minimal hepatic encephalopathy. In: Experimental and Clinical Methods in Hepatic Encephalopathy Research. Springer; 2025:3\u201320 pp.","DOI":"10.1007\/978-1-0716-4354-9_1"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_073","doi-asserted-by":"crossref","unstructured":"Hansen, MKG, Kj\u00e6rgaard, K, Eriksen, LL, Gr\u00f8nkj\u00e6r, LL, Mikkelsen, ACD, Sandahl, TD, et al.. Psychometric methods for diagnosing and monitoring minimal hepatic encephalopathy\u00a0\u2013\u00a0current validation level and practical use. Metab Brain Dis 2022;37:589\u2013605. https:\/\/doi.org\/10.1007\/s11011-022-00913-w.","DOI":"10.1007\/s11011-022-00913-w"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_074","unstructured":"Singh, V. Advancements and applications of MR spectroscopy in neuroimaging: a comprehensive review. Int J Med Sci Clin Res Rev 2024;7:730\u201350.\u200f"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_075","doi-asserted-by":"crossref","unstructured":"Shah, NJ, Neeb, H, Kircheis, G, Engels, P, H\u00e4ussinger, D, Zilles, K. Quantitative cerebral water content mapping in hepatic encephalopathy. Neuroimage 2008;41:706\u201317. https:\/\/doi.org\/10.1016\/j.neuroimage.2008.02.057.","DOI":"10.1016\/j.neuroimage.2008.02.057"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_076","doi-asserted-by":"crossref","unstructured":"Rose, C. Ammonia\u2010lowering strategies for the treatment of hepatic encephalopathy. Clin Pharmacol Therapeut 2012;92:321\u201331. https:\/\/doi.org\/10.1038\/clpt.2012.112.","DOI":"10.1038\/clpt.2012.112"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_077","doi-asserted-by":"crossref","unstructured":"Florou-Paneri, P, Christaki, E, Bonos, E. Lactic acid bacteria as source of functional ingredients. In: Lactic acid cacteria-R & D for food, health and livestock purposes. IntechOpen; 2013.","DOI":"10.5772\/47766"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_078","doi-asserted-by":"crossref","unstructured":"Tomiya, T, Inoue, Y, Yanase, M, Arai, M, Ikeda, H, Tejima, K, et al.. Leucine stimulates the secretion of hepatocyte growth factor by hepatic stellate cells. Biochem Biophys Res Commun 2002;297:1108\u201311. https:\/\/doi.org\/10.1016\/s0006-291x(02)02339-2.","DOI":"10.1016\/S0006-291X(02)02339-2"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_079","doi-asserted-by":"crossref","unstructured":"Hadjihambi, A, Jalan, R. Hepatic encephalopathy: new treatments. Clinical Liver Disease 2015;5:109. https:\/\/doi.org\/10.1002\/cld.468.","DOI":"10.1002\/cld.468"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_080","doi-asserted-by":"crossref","unstructured":"Sturgeon, JP, Shawcross, DL. Recent insights into the pathogenesis of hepatic encephalopathy and treatments. Expert Rev Gastroenterol Hepatol 2014;8:83\u2013100. https:\/\/doi.org\/10.1586\/17474124.2014.858598.","DOI":"10.1586\/17474124.2014.858598"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_081","doi-asserted-by":"crossref","unstructured":"Rai, R, Saraswat, VA, Dhiman, RK. Gut microbiota: its role in hepatic encephalopathy. J\u00a0Clin Exp Hepatol 2015;5:S29\u201336. https:\/\/doi.org\/10.1016\/j.jceh.2014.12.003.","DOI":"10.1016\/j.jceh.2014.12.003"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_082","doi-asserted-by":"crossref","unstructured":"Diakidou, A, Vertzoni, M, Goumas, K, S\u00f6derlind, E, Abrahamsson, B, Dressman, J, et al.. Characterization of the contents of ascending colon to which drugs are exposed after oral administration to healthy adults. Pharm Res 2009;26:2141\u201351. https:\/\/doi.org\/10.1007\/s11095-009-9927-x.","DOI":"10.1007\/s11095-009-9927-x"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_083","doi-asserted-by":"crossref","unstructured":"Zuhl, M, Dokladny, K, Mermier, C, Schneider, S, Salgado, R, Moseley, P. The effects of acute oral glutamine supplementation on exercise-induced gastrointestinal permeability and heat shock protein expression in peripheral blood mononuclear cells. Cell Stress Chaperones 2015;20:85\u201393. https:\/\/doi.org\/10.1007\/s12192-014-0528-1.","DOI":"10.1007\/s12192-014-0528-1"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_084","doi-asserted-by":"crossref","unstructured":"Jalan, R, Wright, G, Davies, N, Hodges, S. L-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy. Med Hypotheses 2007;69:1064\u20139. https:\/\/doi.org\/10.1016\/j.mehy.2006.12.061.","DOI":"10.1016\/j.mehy.2006.12.061"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_085","doi-asserted-by":"crossref","unstructured":"Oria, M, Romero-Gim\u00e9nez, J, Arranz, JA, Riudor, E, Raguer, N, C\u00f3rdoba, J. Ornithine phenylacetate prevents disturbances of motor-evoked potentials induced by intestinal blood in rats with portacaval anastomosis. J\u00a0Hepatol 2012;56:109\u201314. https:\/\/doi.org\/10.1016\/j.jhep.2011.06.026.","DOI":"10.1016\/j.jhep.2011.06.026"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_086","doi-asserted-by":"crossref","unstructured":"Ventura-Cots, M, Arranz, JA, Sim\u00f3n-Talero, M, Torrens, M, Blanco, A, Riudor, E, et al.. Safety of ornithine phenylacetate in cirrhotic decompensated patients: an open-label, dose-escalating, single-cohort study. J\u00a0Clin Gastroenterol 2013;47:881\u20137. https:\/\/doi.org\/10.1097\/mcg.0b013e318299c789.","DOI":"10.1097\/MCG.0b013e318299c789"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_087","doi-asserted-by":"crossref","unstructured":"Hassanein, T, Kittrelle, JP, Cato, J, Fischer, L, Anderson, K. 607 Phase 1\/2A studies with OCR-002 (ornithine phenylacetate); optimized dosing regimen with an ammonia scavenger for treatment of hepatic encephalopathy. J\u00a0Hepatol 2012;607:S240\u20131.","DOI":"10.1016\/S0168-8278(12)60620-5"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_088","doi-asserted-by":"crossref","unstructured":"Lheureux, PE, Hantson, P. Carnitine in the treatment of valproic acid-induced toxicity. Clin Toxicol 2009;47:101\u201311. https:\/\/doi.org\/10.1080\/15563650902752376.","DOI":"10.1080\/15563650902752376"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_089","unstructured":"Jurca, C, Bembea, M, Pallag, A, Mure\u0219an, M, Szilagyi, A, Balmo\u0219, A, et al.. Pharmacotherapeutical considerations in the treatment and management of neonatal hyperammonaemia. FARMACIA 2018;66:216\u201322."},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_090","unstructured":"Misel, ML, Gish, RG, Patton, H, Mendler, M. Sodium benzoate for treatment of hepatic encephalopathy. Gastroenterol Hepatol 2013;9:219."},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_091","doi-asserted-by":"crossref","unstructured":"Phongsamran, PV, Kim, JW, Cupo Abbott, J, Rosenblatt, A. Pharmacotherapy for hepatic encephalopathy. Drugs 2010;70:1131\u201348. https:\/\/doi.org\/10.2165\/10898630-000000000-00000.","DOI":"10.2165\/10898630-000000000-00000"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_092","doi-asserted-by":"crossref","unstructured":"Mangini, C, Montagnese, S. New therapies of liver diseases: hepatic encephalopathy. J\u00a0Clin Med 2021;10:4050. https:\/\/doi.org\/10.3390\/jcm10184050.","DOI":"10.3390\/jcm10184050"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_093","doi-asserted-by":"crossref","unstructured":"Antoine, JM, Faurie, JM, Oozeer, R, van Hylckama Vlieg, J, Knol, J, Bachmann, H, et al.. 20 probiotics and innovation. Probiotics Health Claims 2011;303.","DOI":"10.1002\/9781444329384.ch20"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_094","doi-asserted-by":"crossref","unstructured":"Garcovich, M, Zocco, MA, Roccarina, D, Ponziani, FR, Gasbarrini, A. Prevention and treatment of hepatic encephalopathy: focusing on gut microbiota. World J Gastroenterol: WJG 2012;18:6693. https:\/\/doi.org\/10.3748\/wjg.v18.i46.6693.","DOI":"10.3748\/wjg.v18.i46.6693"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_095","doi-asserted-by":"crossref","unstructured":"Ytreb\u00f8, LM, Kristiansen, RG, Maehre, H, Fuskev\u00e5g, OM, Kalstad, T, Revhaug, A, et al.. L\u2010ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure. Hepatology 2009;50:165\u201374. https:\/\/doi.org\/10.1002\/hep.22917.","DOI":"10.1002\/hep.22917"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_096","doi-asserted-by":"crossref","unstructured":"Jover-Cobos, M, Khetan, V, Jalan, R. Treatment of hyperammonemia in liver failure. Curr Opin Clin Nutr Metab Care 2014;17:105\u201310. https:\/\/doi.org\/10.1097\/mco.0000000000000012.","DOI":"10.1097\/MCO.0000000000000012"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_097","doi-asserted-by":"crossref","unstructured":"Rockey, DC, Vierling, JM, Mantry, P, Ghabril, M, Brown, RS, Alexeeva, O, et al.. Randomized, double\u2010blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy. Hepatology 2014;59:1073\u201383. https:\/\/doi.org\/10.1002\/hep.26611.","DOI":"10.1002\/hep.26611"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_098","doi-asserted-by":"crossref","unstructured":"Hermie, L, Dhondt, E, Vanlangenhove, P, Hoste, E, Geerts, A, Defreyne, L. Model for end-stage liver disease score and hemodynamic instability as a predictor of poor outcome in early transjugular intrahepatic portosystemic shunt treatment for acute variceal hemorrhage. Eur J Gastroenterol Hepatol 2018;30:1441\u20136. https:\/\/doi.org\/10.1097\/meg.0000000000001222.","DOI":"10.1097\/MEG.0000000000001222"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_099","doi-asserted-by":"crossref","unstructured":"Tripathi, D, Stanley, AJ, Hayes, PC, Travis, S, Armstrong, MJ, Tsochatzis, EA, et al.. Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension. Gut 2020;69:1173\u201392. https:\/\/doi.org\/10.1136\/gutjnl-2019-320221.","DOI":"10.1136\/gutjnl-2019-320221"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_100","doi-asserted-by":"crossref","unstructured":"Hoshi, T, Endo, M, Hirai, A, Suzuki, M, Aoyagi, T. Encapsulation of activated carbon into a hollow-type spherical bacterial cellulose gel and its indole-adsorption ability aimed at kidney failure treatment. Pharmaceutics 2020;12:1076. https:\/\/doi.org\/10.3390\/pharmaceutics12111076.","DOI":"10.3390\/pharmaceutics12111076"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_101","doi-asserted-by":"crossref","unstructured":"Bajaj, JS, Wade, JB, Sanyal, AJ. Spectrum of neurocognitive impairment in cirrhosis: implications for the assessment of hepatic encephalopathy. Hepatology 2009;50:2014\u201321. https:\/\/doi.org\/10.1002\/hep.23216.","DOI":"10.1002\/hep.23216"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_102","doi-asserted-by":"crossref","unstructured":"Prakash, RK, Brown, TA, Mullen, KD. Minimal hepatic encephalopathy and driving: is the genie out of the bottle? Am J Gastroenterol 2011;106:1415. https:\/\/doi.org\/10.1038\/ajg.2011.154.","DOI":"10.1038\/ajg.2011.154"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_103","doi-asserted-by":"crossref","unstructured":"Bajaj, JS, Stein, AC, Dubinsky, RM. What is driving the legal interest in hepatic encephalopathy? Clin Gastroenterol Hepatol 2011;9:97\u20138. https:\/\/doi.org\/10.1016\/j.cgh.2010.10.031.","DOI":"10.1016\/j.cgh.2010.10.031"},{"key":"2026072111574555599_j_jbcpp-2025-0166_ref_104","doi-asserted-by":"crossref","unstructured":"Bar-Or, D, Bar-Or, R, Rael, LT, Brody, EN. Oxidative stress in severe acute illness. Redox Biol 2015;4:340\u20135. https:\/\/doi.org\/10.1016\/j.redox.2015.01.006.","DOI":"10.1016\/j.redox.2015.01.006"}],"container-title":["Journal of Basic and Clinical Physiology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2025-0166\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2025-0166\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:58:12Z","timestamp":1784635092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2025-0166\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":104,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,5,28]]},"published-print":{"date-parts":[[2026,7,22]]}},"alternative-id":["10.1515\/jbcpp-2025-0166"],"URL":"https:\/\/doi.org\/10.1515\/jbcpp-2025-0166","relation":{},"ISSN":["0792-6855","2191-0286"],"issn-type":[{"value":"0792-6855","type":"print"},{"value":"2191-0286","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]}}}